The abstract is read at the publisher; the summary is JClub's.
Tumor indolence is an actively maintained state of restrained malignant potential, and aggressiveness emerges as overlapping lineage, epigenetic, immune, stromal, vascular, and metabolic restraints progressively erode or collapse.
- Why it matters: Cancer screening can find lesions that meet malignancy criteria yet stay clinically silent for years or decades, leaving a gap in understanding what prevents malignant potential.
- What they did: The work proposes a multilayer restraint architecture—lineage and epigenetic barriers, epithelial cell competition, immune containment, stromal organization, and vascular and metabolic limitations—and frames progression as restraint erosion rather than a single decisive change.
- The result: This reframing enables predicting when restraint will fail, supporting more rational surveillance, risk stratification, and timely intervention while reducing overdiagnosis and overtreatment.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.